182 related articles for article (PubMed ID: 36856856)
1. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
[TBL] [Abstract][Full Text] [Related]
5. Platelet-rich plasma treatment for melasma: A pilot study.
Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
[TBL] [Abstract][Full Text] [Related]
6. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
7. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
[TBL] [Abstract][Full Text] [Related]
9. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
[TBL] [Abstract][Full Text] [Related]
10. Platelet-rich plasma is a useful therapeutic option in melasma.
Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
[No Abstract] [Full Text] [Related]
11. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study.
Mekawy KMM; Sadek A; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2021 Feb; 20(2):460-465. PubMed ID: 32562337
[TBL] [Abstract][Full Text] [Related]
12. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
El Hadidi H; Mosaad R; Ragab N
Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
[TBL] [Abstract][Full Text] [Related]
14. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
Adel S; Serri A; Abd El-Raheem T
Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
[TBL] [Abstract][Full Text] [Related]
15. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
16. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials.
Feng X; Su H; Xie J
J Clin Pharm Ther; 2021 Oct; 46(5):1263-1273. PubMed ID: 33959984
[TBL] [Abstract][Full Text] [Related]
18. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
Gamea MM; Kamal DA; Donia AA; Hegab DS
J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intense Pulsed Light versus Intradermal Tranexamic Acid for the Management of Melasma.
Asim SA; Iqbal T; Sajid M; Bhatti S
J Coll Physicians Surg Pak; 2024 May; 34(5):522-526. PubMed ID: 38720210
[TBL] [Abstract][Full Text] [Related]
20. Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up.
Lueangarun S; Sirithanabadeekul P; Wongwicharn P; Namboonlue C; Pacharapakornpong S; Juntongjin P; Tempark T
J Clin Aesthet Dermatol; 2020 Aug; 13(8):36-39. PubMed ID: 33178380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
